









Department of Econometrics 




















Forecasting age-specific breast cancer mortality using 
functional data models 
 



















Working Paper 3/05 Forecasting age-speciﬁc breast cancer
mortality using functional data models
Short title Forecasting mortality from breast cancer
Authors Bircan Erbas
Department of Public Health,
The University of Melbourne, VIC 3053, Australia.
Rob J Hyndman
Department of Econometrics and Business Statistics,
Monash University, VIC 3800, Australia.
Dorota M Gertig
Centre for Genetic Epidemiology,
The University of Melbourne, VIC 3053, Australia.
Corresponding author: Bircan Erbas
Department of Public Health,
The University of Melbourne,
Level 2, 723 Swanston Street, Carlton, Victoria 3053, Australia.
Email: b.erbas@unimelb.edu.au.
Telephone: +613 8344 0635. Fax: +613 9349 5815.
1Forecasting mortality from breast cancer
Abstract
Accurateestimatesoffutureage-speciﬁcincidenceandmortalityarecriticalforallocation
ofresources to breast cancer control programs and evaluationof screening programs. The
purposeofthisstudyistoapplyfunctionaldataanalysistechniquestomodelage-speciﬁc
breast cancer mortality time trends, and forecast entire age-speciﬁc mortality function
using a state-space approach.
We use yearly unadjusted breast cancer mortality rates in Australia, from 1921 to 2001
in 5 year age groups (45 to 85+). We use functional data analysis techniques where mor-
tality and incidence are modeled as curves with age as a functional covariate varying
by time. Data is smoothed using nonparametric smoothing methods then decomposed
(using principal components analysis) to estimate basis functions that represent the func-
tional curve. Period effects from the ﬁtted functions are forecast then multiplied by the
basis functions, resulting in a forecast mortality curve with prediction intervals. To fore-
cast, we adopt a state-space approach and an extension of the Pegels modeling frame-
work for selecting among exponential smoothing methods.
Overall, breast cancer mortality rates in Australia remained relatively stable from 1960
to the late 1990’s but declined over the last few years. A set of K=4 basis functions min-
imized the mean integrated squared forecasting error (MISFE) and accounts for 99.3% of
variation around the mean mortality curve. 20 year forecast suggest a continual decline
at a slower rate and stabilize beyond 2010 and by age, forecasts show a decline in all age
groups with the greatest decline in older women.
We illustrate the utility of a new modelling and forecasting approach to model breast
cancer mortality rates using a functional model of age. The methods have the potential
to incorporate important covariates such as Hormone Replacement Therapy (HRT) and
interventions to represent mammographic screening. This would be particularly useful
for evaluating the impact of screening on mortality and incidence from breast cancer.
Keywords: mortality, breast cancer, forecasting, functional data analysis, exponential
smoothing
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Introduction
Despite an increase in utilization of mammographic screening as a form of early detec-
tion, and continual improvements in treatment options, breast cancer remains one of the
main causes of mortality and morbidity in women. Regular and accurate estimates of fu-
ture age-speciﬁc incidence and mortality are necessary in making recommendations for
the allocation of resources to state, regional and private health care, community-based
prevention services and breast cancer control programs.
At present, most forecasting relies on age-period-cohort methods to estimate mortality
(and incidence) from breast cancer [1, 2, 3], prostate cancer [4, 1] and cervical cancer
[5, 6]. These models are based on regressions with the outcome deﬁned as mortality or
incident cases, and modelled using a Poisson error distribution and a log link function
for the mean. The mean is modelled using the sum of parameters for age, period ef-
fects (variations in time which may apply to the whole population) and cohort effects
(variations due to speciﬁc birth cohorts). The ﬁtted models are then used to make linear
projections of mortality and incidence. Common problems associated with age-period-
cohort models for estimating future cancer rates include issues with non-identiﬁability of
the parameters, strong parametric assumptions, and sensitivity of the projections to most
recent changes in cohort effects.
Little other progress has been made in developing statistical methodology for cancer pro-
jections, with studies concentrating on variations of age-period-cohort statistical meth-
ods. Dyba et al. [7] and Dyba and Hakulinen [8] proposed linear extrapolation and
non-linear Poisson distributed models. Each proposal considered a number of different
scenarios with known and linearly extrapolated values for period effects and age-speciﬁc
rates. Bashir and Esteve [3] used a Bayesian age-period-cohort model with autoregress-
ive smoothing of each of the age, period and cohort components so that the resulting
projections are estimated from current and past smoothed trends of the data.
We present an alternative approach to forecasting cancer mortality and incidence. This
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method was recently developed for demographic forecasting [9] and has not previously
been applied to cancer projections. The approach uses functional data analysis tech-
niques, and treats the age-speciﬁc mortality curves as the units of analysis rather than
the discrete observations. In recent years, functional data analysis has received much at-
tention, particularly in medicine. Ramsay and Silverman [10] provide a comprehensive
introduction and have stimulated much additional development of these methods.
The Hyndman-Ullah [9] approach is a generalization of the method of Lee and Carter
[11], and has the following advantages: a) mortality (or incidence) rates are modelled as
continuous functions of age so that subtle patterns of variation between years are cap-
tured; b) data are smoothed prior to estimating the basis functions, thus reducing obser-
vational error; c) the approach forecasts the entire function for future time periods with
prediction intervals; d) the method is robust to outlying years; and e) the ﬂexibility of the
approach allows the incorporation of important covariates such as screening and treat-
ment effects into the modelling. The purpose of this study is to demonstrate the utility
of this new modelling and forecasting method for estimating future age-speciﬁc trends




In this study we obtained data on mortality from breast cancer in Australian women from
the Australian Institute of Health and Welfare (AIHW), an organization that provides de-
identiﬁed health and welfare data to national and regional government and community
organizations. National mortality data are compiled from medical certiﬁcates outlining
cause of death from the Registrar of Births, Deaths and Marriages located in each state
and territory. Additional diagnostic information is also available from the state- and
territory-based cancer registries.
Erbas, Hyndman & Gertig. 7 February 2005 Page 4Forecasting mortality from breast cancer
At present, breast cancer mortality represents 16% of all cancer deaths in Australian wo-
men [12]; 12% of deaths from breast cancer occur in women aged 40 to 49 years, 38.3%
in women aged 50 to 69 years (the target age group for screening) and 46.2% in women
over 70 years of age.
We use crude (unadjusted) age-speciﬁc mortality rates, deﬁned as the number of deaths
in aparticular agegroupduringthe yeardividedby the correspondingpopulation in that
age group at 30 June of the same year. The rate is expressed per 100,000 people. Yearly
age-speciﬁc breast cancer mortality rates were available for the period 1921 to 2001 and
in 5 year age groups (45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79, 80–84, 85+).
Functional data analysis
With functional data methods, data can be smooth curves or functions. In the case of
age-speciﬁc mortality, mortality rates are treated as smooth functions of age.
Let yt(x) denote the log mortality rate for age x and year t, t = 1,...,n. We assume there
is an underlying smooth function ft(x) that we are observing with error. Thus,
yt(xi) = ft(xi) + σt(xi)εt,i , (1)
where xi is the centre of age-group i (i = 1,...,p), εt,i is an independent and identically
distributed standard normal random variable and σt(xi) allows the amount of noise to
vary with age x.
Various smoothing techniques are available to estimate the function from the discrete
observations. We smooth the data using local quadratic smoothing with the smoothing
parameter (the “bandwidth”) selected using cross-validation [13]
The smooth curves are our functional observations, {ft(x)}, x1 < x < xp, t = 1,...,n.
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After constructing the functional observations, we ﬁt the model
ft(x) = µ(x) +
K X
k=1
βt,kφk(x) + et(x) (2)
where µ(x) is the mean log mortality rate across years, φk(x) is a set of orthogonal basis
functions, and et(x) is the model error.











This is achieved using functional principal components decomposition [14] which gives
the least number of basis functions, enables more informative interpretations and gives
coefﬁcients which are uncorrelated with each other.
Hyndman and Ullah [9] proposed a robust method to estimate µ(x) and a robust ap-
proach to obtaining principal components when computing the basis functions. How-
ever, our data do not exhibit any outliers or other unusual behaviour, and so we use the
mean and standard (functional) principal component decomposition.
To assess the overall goodness of ﬁt, the residuals of the ﬁtted mortality model are dis-
played using image plots.
Forecasting framework
We estimate future values of mortality yt(xi) by forecasting the entire function ft(x) for
t = n + 1,...,n + h and x1 < x < xp. The coefﬁcients of the ﬁtted function, βt,1,...,βt,K,
are forecast using time series models. The forecast coefﬁcients are then multiplied by the
basis functions, resulting in forecasts of mortality curves. Hyndman and Ullah [9] show
how to obtain prediction intervals for the forecast curves.
Let ˆ βn,k,h denote the h-step ahead forecast of βn+h,k and let ˆ fn,h(x) denote the h-step
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ahead forecast of fn+h(x). Then
ˆ fn,h(x) = ˆ µ(x) +
K X
k=1
ˆ βn,k,hˆ φk(x). (4)
To forecast the coefﬁcients in equation (4), a variety of time series forecasting methods
are available. In this study we use state space models for exponential smoothing [15].
Forecasts from exponential smoothing methods are estimated recursively where recent
observations are given more weight than historical data. The methods accommodate ad-
ditive and multiplicative trend and seasonal components of the time series. Makridakis,
Wheelwright and Hyndman [16] present a modelling framework based on the taxonomy
proposed by Pegels [17]. The framework is expanded in Hyndman et al. [15], who also
provide state space models for each method, and show how models can be automatically
selected for a given time series.
We evaluate the accuracy of the mortality forecasts by computing the Mean Integrated
Squared Forecasting Error (MISFE) deﬁned as
MISFE(h) =
1




yt+h(x) − ˆ ft,h(x)
i2
dx. (5)
where m is the minimum number of observations used in ﬁtting a model. In our imple-
mentation, we set m = 10.
All analyses were performed using the R implementation of the S language [18].
Results
Descriptives
INSERT FIGURE 1 ABOUT HERE
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Figure 1 displays mortality from breast cancer in Australian women by age group for
period 1921 to 2001. Breast cancer mortality rates remained relatively stable for women
45–49 years of age. For older women, there was an increase in mortality between 1921
and 1940, followed by a decline until 1960 for women aged 55 and 80. All age groups
had relatively stable mortality rates from 1960 to the late 1990s, and all show a decline in
mortality over the last few years. The greatest rate of decline has been in women 65 years
and over. In general, mortality increases with age, and in each year, maximum mortality
occurred in women over 85 years.
INSERT FIGURE 2 ABOUT HERE
Crude log mortality rates by age for 1941, 1961, 1981 and 2001 are displayed in Figure 2.
We smooth the log mortality series by age using loess (locally quadratic) regression with
the bandwidth chosen via cross-validation. The ﬁtted smooth curves are overlaid on the
observed discrete log mortality rates. Similar trends in the age-mortality relation were
observed in each year. Although mortality rates increase with age, the rate of increase
variesacrossagegroups. Inmostyears, thereisaslightdecelerationintherateofincrease
for women 60 to 70 years of age, and a rapid acceleration thereafter.
Functional data analysis
INSERT FIGURE 3 ABOUT HERE
Using functional data analysis techniques and principal component decomposition to es-
timate the basis functions, a model with K = 4 basis functions was selected. A set of
K = 4 basis function minimized the MISFE, while estimating an additional basis func-
tion did not contribute to a further reduction in the MISFE. The estimated basis functions
and corresponding coefﬁcients β1,...,β4 are shown in Figure 3. Fitting a functional re-
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gression model with K = 4 basis functions accounts for 99.3% of the variation around
the mean mortality curve. The proportion of variation explained by each basis function
is 69.3%, 15.8%, 9.1% and 5.0% for k = 1,...,4 respectively.
The ﬁrst basis function corresponds to the overall trend in the mortality curve. The
second describes variation in mortality in lower age groups, capturing the rate of in-
crease in women approximately 50 to 60 years of age relative to older women. The third
contrasts mortality rates in women around 70 with those much younger and those much
older. The fourth component is complex and contrasts those under 55 or between 65 and
80, with the other ages.
Forecasting horizon 20 years
INSERT FIGURE 4 ABOUT HERE
We computed 20 year estimates of future age-speciﬁc breast cancer mortality using state-
space exponential smoothing models as described by Hyndman et al. (2002). The auto-
matic model-selection algorithm chose models with additive errors and a damped trend.
The model parameters were selected by minimization of the one-step MSE.
Forecasts of βt,1 are shown in Figure 4 for 2002 to 2021, along with 80% prediction inter-
vals. This parameter controls the overall change in trend in breast cancer mortality. In
Australian women, mortality from breast cancer is expected to continue to decline at a
slower rate than that suggested by observed mortality trends during the late 1990s, and
expected to level off and stabilize beyond 2010. Note that the wide prediction intervals
provide a measure of the uncertainty in the future movements in this coefﬁcient, and
even allow for it to increase.
INSERT FIGURE 5 ABOUT HERE
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One-year and ten-year Age-speciﬁc breast cancer log mortality forecasts are shown in
Figure 5, along with 80% prediction intervals. Very little difference in the overall shape
of the age-mortality trends is likely to occur over the forecast horizon. In all age groups,
the forecasts show a decline in breast cancer mortality, with the greatest declines in the
oldest age groups.
Discussion
At present, statistical methods for mortality projections assume current age-adjusted
breast cancer mortality trends will continue into the future, thereby projecting a con-
tinual rate of decline in breast cancer mortality in countries such as the United States, the
United Kingdom, Canada, New Zealand and Australia.
In this study of breast cancer mortality in Australian women, we illustrate the utility of
a new forecasting method that models mortality using a functional model of age. The
model uses basis expansions which highlight important trends in the mortality-age rela-
tionship for the period of the study. Future mortality rates are then estimated using all
available historical data rather than only the most recent observations.
Usingourapproach, theforecasthorizonsuggestsaslowerrateofdeclineinbreastcancer
mortality in Australian women within the next decade, stabilizing beyond 2010. Our
data suggest relatively small changes in mortality for women 50 to 60 years of age who
are at the lower end of the target age group for screening, assuming current screening
and treatments are unchanged.
In Australia, crude mortality rates have increased during 1920–1940, decreased post war,
remained relatively stable during 1960–1980, followed by a steady decline since the mid-
1990s. However, when crude mortality rates are age-standardized to the world popula-
tion, Australian mortality trends follow a similar pattern to other Western countries such
as the United States, the United Kingdom, Canada and New Zealand [19, 20]. In these
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countries, mortality rates have shown very little variation beyond 1950 except for the
more recent steady decline which began in the 1990s.
The reduction in mortality over the last decade is most likely a result of improvements in
treatment regimes such as increased utilization of adjuvant therapy and increased mam-
mographic screening. In the United States substantial improvements in survival among
postmenopausal women were observed following new treatment regimes in addition to
tamoxifen [21]. The United Kingdom has adopted tamoxifen treatments in nearly all wo-
men over 50 years of age in the early 1990s [22]. Australia has seen similar improvements
in adjuvant chemotherapy and hormonal therapy treatment regimes [23] and in 1995 new
management guidelines for breast cancer treatment were widely adopted [24].
The more recent reduction in breast cancer mortality rates may in part be explained by
the delayed mortality beneﬁt of mammographic screening.
Although the interpretation of randomized control trials of mammographic screening
is still subject to some controversy [25], the evidence suggests an approximately 30%
reduction in mortality in screened populations due to early detection of tumours. In
many countries, participation in mammographic screening has gradually increased since
its introduction in the late 1980s and early 1990s. In Australia, 57% of women in the target
age group for screening (50 to 69 years) were screened within a national BreastScreen
program in 2001–2002 [12]. Participation rates are much higher in the United States with
78.6% of women between 50–64 years of age reported as having a mammogram in the
previous two years [26].
Blanks et al. [2] predicted mortality from breast cancer for England and Wales using the
widely used age-period-cohort approach. They provide mortality predictions separately
for different age groups in the presence and absence of screening for the period 1990–
1999. Although they do not extrapolate beyond 1999, their ﬁndings suggest a constant
decline in overall mortality, with a slight decline and then levelling off in women 50 to 65
years of age and an increase in women over 70 years of age.
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Verdecchia et al. [27] adopt an alternative survival regression type approach to project
breast cancer mortality, incidence and prevalence for the period 1993–2030 by 5-year age
groups for women in Connecticut. They report a decrease in projected age-adjusted mor-
tality prior to 2003 and then a levelling off with very little variation beyond 2003. Mortal-
ity projections by age suggest a decrease in women 50 to 69 years of age and a continual
increase in women over 70 years of age from 1990, 2000, to 2030. Our forecasts of over-
all mortality are similar to the ﬁndings of Verdecchia et al. [27], although we forecast a
delay in the leveling off of mortality beyond 2010 and not earlier as they suggest. Our
data comprise much longer periods of mortality (1921–2001) and show mortality rates
decreasing most rapidly between 1990 and 2001. Our forecasts incorporate these trends.
In this study we adopt a methodological approach which models age as a functional
covariate rather than a ﬁxed variable, so that the age-shape of mortality varies over time,
thereby enabling the models and forecasts to pick up subtle variations. Other studies
in demography have also realized the implications of this phenomenon when modeling
all-cause mortality, particularly the acceleration in the rate of mortality decline in older
persons [28, 29].
Functional data analysis is an effective exploratory and modelling technique for high-
lighting trends and variations in the shape of the age-mortality relationship over time.
This analytical approach has a number of strengths. First, in contrast to the common age-
period-cohort models used to model trends in mortality, functional data analysis tech-
niques make no parametric assumptions about age or period effects. The shape of the
mortality-age curve varies with time, so that at different ages, mortality declines at differ-
ent rates. This phenomenon is particularly apparent in breast cancer mortality, possibly
due to hormonal effects or screening of women in target age groups. To our knowledge,
no other study has modelled or forecast from a model with age as a functional covariate
of breast cancer mortality over time.
Second, using a functional approach to forecast age-speciﬁc mortality models the entire
age function and allows the possibility of a damped trend component, thereby provid-
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ing greater accuracy when forecasting age-speciﬁc mortality for future time periods. The
damped trend is particularly useful for forecasting breast cancer mortality because in re-
cent years mortality from breast cancer has continued to decrease. Rather than assuming
a continual decline into the future, the damping factor decelerates the trend component
for the forecast horizon. In other forecasting applications [30], a damped trend model has
proved particularly accurate for forecasting.
Functional data analysis methods can be further developed to incorporate interventions
such as screening effects and covariates for hormone replacement therapy use. In addi-
tion, the shape of the age-mortality relation can be allowed to vary for different types of
cancers and would be particularly useful for forecasting incidence of breast cancer.
A potential limitation of this approach is the assumption that there are only period effects
and no cohort effects. Examination of the residuals from the functional ﬁt revealed very
little birth cohort effects in breast cancer mortality in Australia. Furthermore, studies
of breast cancer mortality in different countries using age-cohort mortality models also
support our ﬁnding of constant cohort mortality ratios from breast cancer in Australian
women [19]. However, birth cohort effects are an important component of modelling
mortality trends and studies have shown strong birth cohort effects in mortality trends
for the United Kingdom, Canada, the United States and Scotland [19, 31, 32].
Often birth cohort effects inﬂuence mortality trends in younger and older age groups
[33]. Our modelling approach smooths the data prior to ﬁtting the functional regression
model, resulting in a smoothed functional age-mortality relation. The smoothing process
may reduce much of the variation attributable to outlying observations at younger and
older age groups where we expect birth-cohort trends to have the greatest effect. Any
remaining birth-cohort trend is saturated in patterns of variation over time. This is not
necessarily a problem as it does not hinder the functional age-mortality association over
time, which is the focus of these studies. In future work, we intend to extend our model
to allow for cohort effects.
In summary, we have demonstrated the utility and ﬂexibility of this newly developed
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approach to forecast age-speciﬁc mortality from breast cancer. Our estimates suggest
mortality from breast cancer will continue to decline and then stabilize beyond 2010 with
the greatest decline in oldest age groups. These models also have broader application to
other cancers and chronic diseases.
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Figure 1: Age-speciﬁc mortality from breast cancer, Australia, 1921–2001
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Figure 2: Four years of log mortality from breast cancer by age group in Australia. Loess (locally
quadratic) smooth curves are also shown.
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Figure 3: The components from the functional model for breast cancer mortality in Australia.
Top line: the mean function and ﬁrst four basis functions. Bottom line: the coefﬁcients associated
with each of the basis functions.
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Forecasts from Damped Holt’s method
Year

























Figure 4: Twenty year forecasts of the ﬁrst coefﬁcient using a Holt’s damped trend model. The
shaded region gives 80% prediction intervals.
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Figure 5: Forecast age-speciﬁc breast cancer mortality in Australia for 2002 and 2011, with 80%
prediction intervals. Actual values for 2001 are shown as circles. The forecasts show decreasing
mortality for all ages, with the greatest decreases for the oldest women.
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